BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Tetraphase Pharmaceuticals Appoints Kam Unninayar as Chief Financial Officer

  Tetraphase Pharma today announced the appointment of Kamalam (Kam) Unninayar as Chief Financial Officer.

  October 16, 2017

   · 

  4 min read
• Business

  Applied BioMath, LLC announces collaboration with Sanofi for quantitative systems pharmacology modeling in immuno-oncology

  Applied BioMath today announced a collaboration with Sanofi to develop QSP models in immuno-oncology.

  October 16, 2017

   · 

  2 min read
• Biotech Bay

  IGeneX Inc. Introduces New Diagnostic Tests for Lyme Disease and Tick-Borne Relapsing Fever

  IGeneX Inc. announce the launch of three new tests that are more inclusive and specific for aiding in diagnosis of Borreliosis (Lyme Disease and Tick-Borne Relapsing Fever, Borreliosis).

  October 16, 2017

   · 

  3 min read
• Drug Development

  Zogenix’s Interim Survey Results Demonstrate Impact on Siblings of Children Suffering from Severe Epilepsy

  Findings Presented by Zogenix at the NORD Rare Diseases and Orphan Products Breakthrough Summit in Washington, D.C.

  October 16, 2017

   · 

  5 min read
• Drug Development

  Atara Biotherapeutics Announces Abstract Publication for Two MSParis2017 Congress Presentations, Including Updated Interim Results from a Phase I Study of Autologous ATA190 in Patients with Progressive MS

  Five of eight progressive MS patients who received the full course of autologous ATA190 experienced clinical improvements.

  October 16, 2017

   · 

  8 min read
• Business

  T2 Biosystems Announces 2017 Third Quarter Financial and Operational Results Release and Conference Call Date

  T2 Biosystems will release its 2017 third quarter financial and operational results after the market closes on Thursday, November 2, 2017.

  October 16, 2017

   · 

  2 min read
• Genetown

  Leader of Johnson & Johnson 3D Printing Center of Excellence Outlines Advantages of Customized Knee Implants

  ConforMIS has obtained additional positive clinical data regarding the performance of its customized partial knee replacement implants.

  October 16, 2017

   · 

  5 min read
• Business

  Silicon Therapeutics Appoints Dr. Christopher Winter As Chief Of R&D

  Silicon Therapeutics announced today the appointment of Dr. Christopher Winter as Chief of R&D. Dr. Winter joins Silicon Therapeutics from Sanofi.

  October 16, 2017

   · 

  3 min read
• Business

  Aeglea BioTherapeutics Inks Clinical Collaboration with Merck

  Aeglea and Merck will evaluate the combination of Aeglea’s AEB1102 with Merck’s anti-PD-1 therapy, KEYTRUDA for the treatment of patients with small cell lung cancer.

  October 16, 2017

   · 

  4 min read
• Drug Development

  Ovid Therapeutics Announces Positive Preclinical OV101 Data Demonstrating Behavioral Improvements in Fragile X Syndrome Model

  Ovid announced new positive preclinical data on OV101 that shows normalization of behavioral abnormalities that resemble those seen in people with Fragile X syndrome.

  October 16, 2017

   · 

  6 min read